Federated Hermes, Inc. Akebia Therapeutics, Inc. Transaction History
Federated Hermes, Inc.
- $50.2 Billion
- Q2 2025
A detailed history of Federated Hermes, Inc. transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 617,318 shares of AKBA stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
617,318
Previous 913,449
32.42%
Holding current value
$1.8 Million
Previous $1.75 Million
28.18%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding AKBA
# of Institutions
170Shares Held
106MCall Options Held
134KPut Options Held
262K-
Vanguard Group Inc Valley Forge, PA14.6MShares$42.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$34 Million0.0% of portfolio
-
State Street Corp Boston, MA8MShares$23.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.07MShares$17.7 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$16.8 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $537M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...